Guest Speaker: Dr. Mark Ereth, Emeritus Professor of Anesthesiology, Mayo Clinic College of Medicine
Dr. Ereth reviews his recent paper Characterization and Novel Mitigation of Aerosolized Transmission of SARS-CoV-2 Virus. The paper reviews:
- How airborne pathogens are spread
- Characteristics of bioaerosols
- Characteristics of viruses
- Effectiveness of conventional air filtration devices
- Effectiveness of other air treatment technologies
- Particle Control Technology has been proven to be effective at removing and destroying airborne pathogens
This webinar was delivered on a Zoom platform, Apr 16, 2020 12:30 PM Central Time (US and Canada).
(Access Password: u0=D1C1Y)
Mark Ereth, MD, Emeritus Professor of Anesthesiology, Mayo Clinic College of Medicine, Co-Founder and CEO, APRI Health, Inc.
Dr. Ereth is an internationally known expert in anesthesiology, transfusion, platelet function, and blood management who is a frequent speaker at medical schools and hospitals around the world. Dr. Ereth’s career has been marked by innovation and collaboration. In his 25 years at the Mayo Clinic he provided anesthesia and critical care to over 10,000 patients and authored more than one hundred peer reviewed journal articles and abstracts. He holds multiple patents for medical devices and upon retirement from the Mayo Clinic he founded Apri Health, Inc., where his team focuses on novel analytic solutions to common problems of patient safety and over-utilization. Mark also co-founded Cheetah Development, a non-profit based on a novel method of funding, Micro-Venture Capital.